Stuart McLachlan
Corporate Officer/Principal presso Lypanosys Pte Ltd.
Profilo
Stuart McLachlan is currently working as the Executive Vice President-Clinical Trials at Lypanosys Pte Ltd.
He holds a doctorate degree from the University of California, Davis.
Posizioni attive di Stuart McLachlan
| Società | Posizione | Inizio |
|---|---|---|
Lypanosys Pte Ltd.
 Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Corporate Officer/Principal | 06/06/2011 |
Formazione di Stuart McLachlan
| University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Lypanosys Pte Ltd.
Lypanosys Pte Ltd. Pharmaceuticals: MajorHealth Technology Lypanosys Pte Ltd. engages in the development of clinically differentiated drug for dermatology. Its initial drug compound, LYP-010 is formulated as an oral systemic drug for the treatment of atopic dermatitis. The company was founded in 1997 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Stuart McLachlan
